knowledge -WSS

knowledge

author：comprehensive 2025-09-30 00:03:43 - browse：7581

a man holds his vaccination reminder card and a "CVS Health" sticky note. -- health business coverage from STAT — Wilfredo Lee/AP

Medicare Advantage members continue to go to the doctor and get health care procedures a lot more than predicted, CVS Health executives said at the J.P. Morgan Healthcare Conference on Monday.

A persistent theme for health insurance companies throughout 2023 has been their Medicare Advantage members using more care than their actuaries projected, which has been eating into the profits they get from federally funded health care premiums.

CVS, a major seller of Medicare Advantage plans, has not yet closed the books on its 2023 finances. But CVS’ new CFO, Tom Cowhey, disclosed on Monday that costs for its Medicare Advantage members now “might exceed” their already-elevated guidance from November as the company sifts through fourth-quarter data.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： STAT Summit: The economic case for universal basic health care

WSS

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Merck, Daiichi strike cancer drug pact worth up to $22 billion

STAT Readout Newsletter: Biotech news today

The problem with charging patients to message their doctors

STAT Readout Newsletter: Biotech news today

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

focus

knowledge

focus

Activists slam private health insurers over coverage restrictions

IVF, abortion rights issues kick off Biden’s State of the Union

23andMe had bad news about my health. I wish a person had delivered it

Sen. Paul opposes bill to ban Chinese biotechs

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Trump demands the U.S. pay no more for drugs than other countries … again

The problems with dementia villages

How one medical school became remarkably diverse

Readout LOUD podcast: Live from the 2023 STAT Summit

focus

Roivant's CEO is a star, but biotech's black hole persists

With psoriasis trial ahead, Alumis raises $259 million

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

How to bring more disabled researchers into academia

The problem with charging patients to message their doctors

What it’s like to watch children die of measles

hotspot

hotspot

hotspot

focus